Hydroxyapatite powder and process for producing same, composition based on this powder and process for preparing same and kit comprising this powder
US11338034B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 4, 2014 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Jul 11, 2039 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB01J2220/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a hydroxyapatite and/or tricalcium phosphate powder characterized in that it has undergone at least one sintering step at a temperature between 400° C. and 600° C. The invention also relates to a process for preparing such a powder, and to a composition comprising such a powder for use as an anti-tumour auto-vaccine and particularly in the treatment of the following pathological conditions: osteosarcoma, B or T lymphoma, mammary tumour, melanoma, haemangiosarcoma, mastocytoma, fibrosarcoma, brain tumours and schwannoma in a subject. The present invention also covers a drug combination comprising the composition of the invention and at least one second therapeutic agent, preferably an anti-tumour agent and/or a radiotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.